Imatinib for the treatment of unresectable and/or metastatic gastrointestinal stromal tumours

Technology appraisal guidance
Reference number: TA209
Published: 24 November 2010

TA209 Imatinib for gastrointestinal stromal tumours: Appendix A - provisional matrix of stakeholders

TA209 Imatinib for gastrointestinal stromal tumours: Appendix A - provisional matrix of stakeholders

TA209 Imatinib for gastrointestinal stromal tumours: Appendix A - provisional matrix of stakeholders
27 August 2013
(101.59 Kb 29 sec)

Adobe Acrobat reader required.

Adobe Acrobat reader required.

This page was last updated: 01 October 2013